Current Controversies in Oncology and Current Insights in Oncology articles provide a forum for the exchange of views on topical issues in the field of oncology. The opinions expressed are those of the authors alone. They do not necessarily reflect the views of the Editor or ASCO.
Apr 25, 2018
Drs. Sarah W. Gordon, Sarah M. Temkin, Debra L. Richardson, and Kathleen Moore debate the role of maintenance PARP in platinum-sensitive ovarian cancer.
Dec 20, 2017
Lymphoma expert Dr. Murali Janakiram answers a question posed at a 2017 Best of ASCO Meeting: Is there a role for maintenance lenalidomide after autologous hematopoietic stem cell transplantation in patients with relapsed diffuse large B-cell lymphoma?
Oct 23, 2017
Dr. Dhaval Shah and Dr. Gregory Masters argue for targeted testing for activating and actional mutations in non-small cell lung cancer, while Dr. Travis Osterman and Dr. Leora Horn make the case for next-generation sequencing.
Aug 31, 2017
In this excerpt from the 2017 ASCO Educational Book, the author highlights the challenges of medical journalism and how the quality and accuracy of news has the potential to alter health outcomes.
Jul 14, 2017
In this excerpt from the 2017 ASCO Educational Book, four experts from different fields offer perspectives on how to address the challenging question of cost of care.
May 02, 2017
Dr. George D. Demetri and Dr. Jaap Verweij debate whether physicians should use olaratumab as a new standard of care for patients with metastatic STS today, or wait until the phase III trial results are available.
Mar 02, 2017
In this excerpt from the 2016 ASCO Educational Book, the authors describe the development of soluble factors, such as serum proteins, as biomarkers in immunotherapy.
Dec 22, 2016
Dr. Gary W. Falk and Drs. Christopher H. Blevins and Prasad G. Iyer debate whether or not to screen patients for Barrett's esophagus. Introduction by Dr. Srinadh Komanduri.
Oct 20, 2016
Dr. Filipa Lynce and Dr. Claudine Isaacs discuss the pros and cons of single/limited gene testing versus multigene panels for identifying hereditary susceptibility to cancer in this excerpt from the 2016 ASCO Educational Book.
Adjuvant Treatment for R0, Tumor-Free Rectal Carcinoma Following Neoadjuvant Treatment: The Case for and Against
Aug 10, 2016
Drs. Bruce D. Minsky and Bengt Glimelius debate the use of adjuvant treatment for R0, tumor-free rectal carcinoma following neoadjuvant treatment, with an introduction by Dr. Bertram Wiedenmann.